General Oncology, Inc.

CIK 1658021 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for General Oncology, Inc..

Recent SEC filings

FiledFormAccession number
Apr 23, 2026D0001658021-26-000006
Jul 2, 2025D/A0001658021-25-000002
Jul 2, 2024D/A0001658021-24-000001
Dec 21, 2023D/A0001658021-23-000001
Dec 22, 2022D/A0001658021-22-000002
Nov 10, 2022D/A0001658021-22-000001
Nov 10, 2021D/A0001658021-21-000002
Dec 23, 2020D/A0001658021-20-000002
Jul 14, 2020D/A0001658021-20-000001
Jul 9, 2019D0001658021-19-000001
Sep 5, 2017D/A0001658021-17-000001
Nov 16, 2015D0001658021-15-000001